BACKGROUND: Gd targets in quantity and quality sufficient for first application in patients. METHODS: Tb on peptide disintegration. RESULTS: Lu, was stable over 24 h in the presence of a stabilizer. CONCLUSIONS: in quality suitable for high-specific radiolabeling, relevant for future clinical application.
No takes yet. Share an insight, caveat, or question.
Gracheva et al. (2019) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: